Neogenomics Stock Price Prediction
| NEO Stock | USD 12.38 0.09 0.72% |
Momentum 61
Buy Extended
Oversold | Overbought |
Using NeoGenomics hype-based prediction, you can estimate the value of NeoGenomics from the perspective of NeoGenomics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in NeoGenomics to buy its stock at a price that has no basis in reality. In that case, they are not buying NeoGenomics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NeoGenomics after-hype prediction price | USD 12.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NeoGenomics | Build AI portfolio with NeoGenomics Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeoGenomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeoGenomics After-Hype Price Density Analysis
As far as predicting the price of NeoGenomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NeoGenomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NeoGenomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NeoGenomics Estimiated After-Hype Price Volatility
In the context of predicting NeoGenomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NeoGenomics' historical news coverage. NeoGenomics' after-hype downside and upside margins for the prediction period are 9.89 and 14.87, respectively. We have considered NeoGenomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NeoGenomics is not too volatile at this time. Analysis and calculation of next after-hype price of NeoGenomics is based on 3 months time horizon.
NeoGenomics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as NeoGenomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeoGenomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NeoGenomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 2.49 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.38 | 12.38 | 0.00 |
|
NeoGenomics Hype Timeline
On the 28th of January NeoGenomics is traded for 12.38. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NeoGenomics is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.43%. %. The volatility of related hype on NeoGenomics is about 0.0%, with the expected price after the next announcement by competition of 12.38. About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeoGenomics has Price/Earnings (P/E) ratio of 272.37. The entity recorded a loss per share of 0.89. The firm had not issued any dividends in recent years. NeoGenomics had 1:100 split on the 16th of April 2003. Considering the 90-day investment horizon the next forecasted press release will be uncertain. Check out NeoGenomics Basic Forecasting Models to cross-verify your projections. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.NeoGenomics Related Hype Analysis
Having access to credible news sources related to NeoGenomics' direct competition is more important than ever and may enhance your ability to predict NeoGenomics' future price movements. Getting to know how NeoGenomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NeoGenomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| XGN | Exagen Inc | 0.00 | 0 per month | 0.00 | (0.52) | 2.88 | (6.15) | 17.46 | |
| MDXH | MDxHealth SA ADR | 0.00 | 0 per month | 0.00 | (0.12) | 6.96 | (7.42) | 17.05 | |
| STXS | Stereotaxis | 0.00 | 0 per month | 0.00 | (0.06) | 4.69 | (4.88) | 18.81 | |
| ACRS | Aclaris Therapeutics | 0.00 | 0 per month | 4.69 | 0.09 | 8.62 | (7.99) | 84.20 | |
| QTRX | Quanterix Corp | 0.00 | 0 per month | 3.24 | 0.10 | 8.16 | (5.14) | 34.06 | |
| SGMT | Sagimet Biosciences Series | 0.00 | 0 per month | 0.00 | (0.13) | 5.37 | (7.51) | 23.02 | |
| SMTI | Sanara Medtech | 0.00 | 0 per month | 0.00 | (0.1) | 5.60 | (4.68) | 26.42 | |
| ARCT | Arcturus Therapeutics Holdings | 0.00 | 0 per month | 0.00 | (0.11) | 6.10 | (6.72) | 15.98 | |
| HUMA | Humacyte | 0.00 | 0 per month | 0.00 | (0.15) | 8.16 | (8.13) | 20.54 | |
| TKNO | Alpha Teknova | 0.00 | 0 per month | 0.00 | (0.21) | 4.75 | (6.50) | 19.09 |
NeoGenomics Additional Predictive Modules
Most predictive techniques to examine NeoGenomics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeoGenomics using various technical indicators. When you analyze NeoGenomics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeoGenomics Predictive Indicators
The successful prediction of NeoGenomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NeoGenomics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NeoGenomics based on analysis of NeoGenomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NeoGenomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeoGenomics's related companies.
Pair Trading with NeoGenomics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoGenomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoGenomics will appreciate offsetting losses from the drop in the long position's value.Moving together with NeoGenomics Stock
| 0.61 | PPERY | Bank Mandiri Persero Earnings Call Next Week | PairCorr |
Moving against NeoGenomics Stock
| 0.72 | PBCRY | Bank Central Asia | PairCorr |
| 0.67 | HPQ | HP Inc | PairCorr |
| 0.51 | MSFT | Microsoft Aggressive Push | PairCorr |
| 0.49 | T | ATT Inc Earnings Call This Week | PairCorr |
| 0.43 | BKRKY | Bank Rakyat | PairCorr |
The ability to find closely correlated positions to NeoGenomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoGenomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoGenomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoGenomics to buy it.
The correlation of NeoGenomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoGenomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out NeoGenomics Basic Forecasting Models to cross-verify your projections. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Stock sector continue expanding? Could NeoGenomics diversify its offerings? Factors like these will boost the valuation of NeoGenomics. Anticipated expansion of NeoGenomics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NeoGenomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate NeoGenomics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating NeoGenomics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause NeoGenomics' market price to deviate significantly from intrinsic value.
It's important to distinguish between NeoGenomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NeoGenomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, NeoGenomics' market price signifies the transaction level at which participants voluntarily complete trades.